CSL Behring is a biotechnology company located in King of Prussia, Pennsylvania, specializing in the development and manufacture of biopharmaceutical products. Situated in the 19406 postal code area, the company focuses on providing innovative therapies that address serious medical conditions through advanced biotechnology methods. Its facilities support a range of scientific and production activities that contribute to the broader healthcare industry.
Operating within the biotechnology sector, CSL Behring emphasizes research and development to improve patient outcomes. The company’s presence in King of Prussia reflects a commitment to integrating cutting-edge technology with rigorous scientific processes. This enables the production of specialized treatments designed to meet the needs of individuals with rare and complex diseases, underscoring the critical role biotechnology companies play in modern medicine.
CSL Behring’s location in Pennsylvania positions it within a region known for its concentration of life sciences organizations and research institutions. This environment fosters collaboration and innovation, allowing the company to stay at the forefront of biotechnological advancements. The business maintains operational efficiency and dependable scheduling to support ongoing projects and customer requirements, reflecting its structured approach to service and production.
With a focus on delivering high-quality biopharmaceutical products, CSL Behring contributes to the local economy and healthcare landscape in King of Prussia. The company’s activities extend beyond manufacturing to encompass continuous improvements in biotechnology processes, aligning with industry standards and scientific developments. Contact can be made via telephone at 610-878-4841 for inquiries related to its biotechnology services and offerings.


































